Ami Organics has developed and commercialised 450 intermediates for active ingredients in 17 key therapeutic areas, and supplies to 150 companies in India and abroad. From the IPO proceeds, Rs 140 crore is to be used to repay debt and ₹90 crore towards funding capital expenditure.
https://ift.tt/3BIqooz
0 Comments